Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alderton, F., Lauder, H., Feniuk, W., Fan, T. P., and Humphrey, P. P. (1998). Differential effects of somatostatin and angiopeptin on cell proliferation. Br J Pharmacol 124, 323–30.
Bass, R. T., Buckwalter, B. L., Patel, B. P., Pausch, M. H., Price, L. A., Strnad, J., Hadcock, J. R. (1996). Identification and characterization of novel somatostatin antagonists. Mol Pharmacol 50, 709–15.
Bauters, C., de Groote, P., Adamantidis, M., Delcayre, C., Hamon, M., Lablanche, J. M., Bertrand, M. E., Dupuis, B., and Swynghedauw, B. (1992). Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? Fur Heart J 13, 556–9.
Bauters, C., Van Belle, E., Wernert, N., Delcayre, C., Thomas, F., Dupuis, B., Lablanche, J. M., Bertrand, M. E., and Swynghedauw, B. (1994). Angiopeptin inhibits oncogene induction in rabbit aorta after balloon denudation. Circulation 89, 2327–31.
Benditt, E. P., and Benditt, J. M. (1973). Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70, 1753–6.
Bruns, C., Shi, V., Hoyer, D., Schuurman, H., and Weckbecker, G. (2000). Somatostatin receptors and the potential use of Sandostatin to interfere with vascular remodelling. Eur J Endocrinol 143, S3–7.
Chen, J. C., Hsiang, Y. N., and Buchan, A. M. (1997). Somatostatin receptor expression in rat iliac arteries after balloon injury. J Invest Surg 10, 17–23.
Chen, L., Hoeger, C., Rivier, J., Fitzpatrick, V. D., Vandlen, R. L., and Tashjian, A. H. (1999). Structural basis for the binding specificity of a SSTR1-selective analog of somatostatin. Biochem Biophys Res Commun 258, 689–94.
Curtis, S. B., Chen, J. C., Winkelaar, G., Turnbull, R. G., Hewitt, J., Buchan, A. M., and Hsiang, Y. N. (2000a). Effect of endothelial and adventitial injury on somatostatin receptor expression. Surgery 127, 577–83.
Curtis, S. B., Hewitt, J., Yakubovitz, S., Anzarut, A., Hsiang, Y. N., and Buchan, A. M. (2000b). Somatostatin receptor subtype expression and function in human vascular tissue. Am J Physiol Heart Circ Physiol 278, H1815–22.
Danesi, R., Agen, C., Benelli, U., Paolo, A. D., Nardini, D., Bocci, G., Basolo, F., Campagni, A., and Tacca, M. D. (1997). Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995). Clin Cancer Res 3, 265–72.
Du Toit, D., Aavik, E., Taskinen, E., Myburgh, E., Aaltola, E., Aimonen, M., Aavik, S., van Wyk, J., and Häyry, P. (2001). Structure of carotid artery in baboon and rat and differences in their response to endothelial denudation angioplasty. 2001 33, 63–78.
Emanuelsson, H., Beatt, K. J., Bagger, J. P., Balcon, R., Heikkila, J., Piessens, J., Schaeffer, M., Suryapranata, H., and Foegh, M. (1995). Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographie restenosis. European Angiopeptin Study Group. Circulation 91, 1689–96.
Eriksen, U. H., Amtorp, O., Bagger, J. P., Emanuelsson, H., Foegh, M., Henningsen, P., Saunamaki, K., Schaeffer, M., Thayssen, P., and Orskov, H. (1995). Randomized double-blind Scandinavian trial of angiopeptin versus placebo for the prevention of clinical events and restenosis after coronary balloon angioplasty. Am Heart J 130, 1–8.
Ferns, G. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., and Ross, R. (1991). Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129–32.
Foegh, M. L., Asotra, S., Conte, J. V., Howell, M., Kagan, E., Verma, K., and Ramwell, P. W. (1994). Early inhibition of myointimal proliferation by angiopeptin after balloon catheter injury in the rabbit. J Vasc Surg 19, 1084–91.
Foegh, M. L., and Ramwell, P. W. (1995). Angiopeptin: experimental and clinical studies of inhibition of myointimal proliferation. Kidney Int Suppl 52, S18–22.
Frystyk, J., Skjaerbaek, C., Alexander, N., Emanuelsson, H., Suryapranata, H., Beyer, H., Foegh, M., and Orskov, H. (1996). Lanreotide reduces serum free and total insulin-like growth factor-I after angioplasty. Circulation 94, 2465–71.
Grant, M. B., Wargovich, T. J., Ellis, E. A., Caballero, S., Mansour, M., and Pepine, C. J. (1994). Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation 89, 1511–7.
Hayry, P., Isoniemi, H., Yilmaz, S., Mennander, A., Lemstrom, K., Raisanen-Sokolowski, A., Koskinen, P., Ustinov, J., Lautenschlager, I., and Taskinen, E. (1993a). Chronic allograft rejection. Immunol Rev 134, 33–81.
Hayry, P., Myllarniemi, M., Aavik, E., Alatalo, S., Aho, P., Yilmaz, S., Raisanen-Sokolowski, A., Cozzone, G., Jameson, B. A., and Baserga, R. (1995). Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. Faseb J 9, 1336–44.
Hayry, P., Raisanen, A., Ustinov, J., Mennander, A., and Paavonen, T. (1993b). Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. Faseb J 7, 1055–60.
Hong, M. K., Kent, K. M., Tio, F. O., Foegh, M., Kornowski, R., Bramwell, O., Cathapermal, S. S., and Leon, M. B. (1997). Single-dose intramuscular administration of sustained-release Angiopeptin reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model. Coron Artery Dis 8, 101–4.
Howell, M., Orskov, H., Frystyk, J., Flyvbjerg, A., Gronbaek, H., and Foegh, M. (1994). Lanreotide, a somatostatin analogue, reduces insulin-like growth factor I accumulation in proliferating aortic tissue in rabbits in vivo. A preliminary study. Eur J Endocrinol 130, 422–5.
Howell, M. H., Adams, M. M., Wolfe, M. S., Foegh, M. L., and Ramwell, P. W. (1993). Angiopeptin inhibition of myointimal hyperplasia after balloon angioplasty of large arteries in hypercholesterolaemic rabbits. Clin Sci (Colch) 85, 183–8.
Khare, S., Kumar, U., Sasi, R., Puebla, L., Calderon, L., Lemstrom, K., Hayry, P., and Patel, A. Y. (1999). Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty. Faseb J 13, 387–94.
Kraiss, L. W., Raines, E. W., Wilcox, J. N., Seifert, R. A., Barrett, T. B., Kirkman, T. R., Hart, C. E., Bowen-Pope, D. F., Ross, R., and Clowes, A. W. (1993). Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest 92, 338–48.
Lauder, H., Sellers, L. A., Fan, T. P., Feniuk, W., and Humphrey, P. P. (1997). Somatostatin sst5 inhibition of receptor mediated regeneration of rat aortic vascular smooth muscle cells. Br J Pharmacol 122, 663–70.
Liapakis, G., Hoeger, C., Rivier, J., and Reisine, T. (1996). Development of a selective agonist at the somatostatin receptor subtype sstrl. J Pharmacol Exp Ther 276, 1089–94.
Lundergan, C., Foegh, M. L., Vargas, R., Eufemio, M., Bormes, G. W., Kot, P. A., and Ramwell, P. W. (1989). Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Atherosclerosis 80, 49–55.
Mennander, A., Raisanen, A., Paavonen, T., and Hayry, P. (1993). Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis. Transplantation 55, 124–8.
Miano, J. M., Tota, R. R., Vlasic, N., Danishefsky, K. J., and Stemerman, M. B. (1990). Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal. Am J Pathol 137, 761–5.
Myllarniemi, M., Calderon, L., Lemstrom, K., Buchdunger, E., and Hayry, P. (1997). Inhibition of platelet-derived growth factor receptor tyrosine kinase inhibits vascular smooth muscle cell migration and proliferation. Faseb J 11, 1119–26.
Patel, Y. C. (1999). Somatostatin and its receptor family. Front Neuroendocrinol 20, 157–98.
Patel, Y. C., Greenwood, M. T., Panetta, R., Demchyshyn, L., Niznik, H., and Srikant, C. B. (1995). The somatostatin receptor family. Life Sci 57, 1249–65.
Patel, Y. C., and Srikant, C. B. (1994). Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1–5). Endocrinology 135, 2814–7.
Plissonnier, D., Nochy, D., Poncet, P., Mandet, C., Hinglais, N., Bariety, J., and Michel, J. B. (1995). Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 60, 414–24.
Reisine, T., and Bell, G. I. (1995). Molecular biology of somatostatin receptors. Endocr Rev 16, 427–42.
Reubi, J. C., Horisberger, U., and Laissue, J. (1994a). High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer 56, 681–8.
Reubi, J. C., Mazzucchelli, L., and Laissue, J. A. (1994b). Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology 106, 951–9.
Reubi, J. C., Schaer, J. C., Laissue, J. A., and Waser, B. (1996a). Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 45, 39–41.
Reubi, J. C., Schaer, J. C., Wenger, S., Hoeger, C., Erchegyi, J., Waser, B., and Rivier, J. (2000). SST3-selective potent peptidic somatostatin receptor antagonists. Proc Natl Acad Sci USA 97, 13973–8.
Reubi, J. C., Waser, B., Laissue, J. A., and Gebbers, J. O. (1996b). Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res 56, 1922–31.
Rohrer, S. P., Birzin, E. T., Mosley, R. T., Berk, S. C., Hutchins, S. M., Shen, D. M., Xiong, Y., Hayes, E. C., Parmar, R. M., Foor, F., Mitra, S. W., Degrado, S. J., Shu, M., Klopp, J. M., Cai, S. J., Blake, A., Chan, W. W., Pasternak, A., Yang, L., Patchett, A. A., Smith, R. G., Chapman, K. T., and Schaeffer, J. M. (1998). Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282, 737–40.
Ross, R. (1999). Atherosclerosis-an inflammatory disease. N Engl J Med 340, 115–26.
Sakamoto, H., Sakamaki, T., Kanda, T., Ito, Y., Sumino, H., Masuda, H., Ohyama, Y., Ono, Z., Kurabayashi, M., Kobayashi, I., and Nagai, R. (1998). The somatostatin analog, octreotide, inhibits in vitro outgrowth of smooth muscle cells from canine coronary and carotid atherosclerotic plaque tissues. Res Commun Mol Pathol Pharmacol 101, 25–34.
Santoian, E. D., Schneider, J. E., Gravanis, M. B., Foegh, M., Tarazona, N., Cipolla, G. D., and King, S. B. (1993). Angiopeptin inhibits intimai hyperplasia after angioplasty in porcine coronary arteries. Circulation 88, 11–4.
Sarkar, R., Dickinson, C. J., and Stanley, J. C. (1999). Effects of somatostatin, somatostatin analogs, and endothelial cell somatostatin gene transfer on smooth muscle cell proliferation in vitro. J Vasc Surg 29, 685–93.
Schuurman, H. J., Beckmann, N., Briner, U., Bruns, C., Bruttel, K., Tanner, M., Tolcsvai, L., and Weckbecker, G. (1996). Magnetic resonance imaging in assessment of rejection of a kidney allograft in the rat: effect of the somatostatin analogue SMS 201–995. Transplant Proc 28, 3272–5.
Schwartz, S. M., deBlois, D., and O’Brien, E. R. (1995). The intima. Soil for atherosclerosis and restenosis. Circ Res 77, 445–65.
Schwartz, S. M., and Murry, C. E. (1998). Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 49, 437–60.
Sihvola, R., Koskinen, P., Myllarniemi, M., Loubtchenkov, M., Hayry, P., Buchdunger, E., and Lemstrom, K. (1999). Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor. Circulation 99, 2295–301.
Smith, L. E., Shen, W., Perruzzi, C., Soker, S., Kinose, F., Xu, X., Robinson, G., Driver, S., Bischoff, J., Zhang, B., Schaeffer, J. M., and Senger, D. R. (1999). Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5, 1390–5.
Thyberg, J., Hedin, U., Sjolund, M., Palmberg, L., and Bottger, B. A. (1990). Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 10, 966–90.
Vargas, R., Wroblewska, B., Rego, A., Cathapermal, S., and Ramwell, P. W. (1997). Angiopeptin inhibits thymidine incorporation by expiants of porcine coronary arteries. J Cardiovasc Pharmacol 29, 278–83.
von Essen, R., Ostermaier, R., Grube, E., Maurer, W., Tebbe, U., Erbel, R., Roth, M., Oel, W., Brom, J., and Weidinger, G. (1997). Effects of octreotide treatment on restenosis after coronary angioplasty: results of the VERAS study. VErringerung der Restenoserate nach Angioplastie durch ein Somatostatin-analogon. Circulation 96, 1482–7.
Weckbecker, G., Pally, C., Raulf, F., Beckmann, N., Schuurman, J. H., Rudin, M., and Bruns, C. (1997). The somatostatin analog octreotide as potential treatment for re-stenosis and chronic rejection. Transplant Proc 29, 2599–600.
Yamashita, M., Dimayuga, P., Kaul, S., Shah, P. K., Regnstrom, J., Nilsson, J., and Cercek, B. (1999). Phosphatase activity in the arterial wall after balloon injury: effect of somatostatin analog octreotide. Lab Invest 79, 935–44.
Yumi, K., Fagin, J. A., Yamashita, M., Fishbein, M. C., Shah, P. K., Kaul, S., Niu, W., Nilsson, J., and Cercek, B. (1997). Direct effects of somatostatin analog octreotide on insulin-like growth factor-I in the arterial wall. Lab Invest 76, 329–38.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Häyry, P., Aavik, E. (2004). Vascular Effects of Somatostatin. In: Srikant, C.B. (eds) Somatostatin. Endocrine Updates, vol 24. Springer, Boston, MA. https://doi.org/10.1007/1-4020-8033-6_17
Download citation
DOI: https://doi.org/10.1007/1-4020-8033-6_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7799-9
Online ISBN: 978-1-4020-8033-3
eBook Packages: Springer Book Archive